Trexall is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Women's Health, Inc.. The primary component is Methotrexate Sodium.
Product ID | 51285-367_3049c3a2-587a-447d-b6e6-823f43629bde |
NDC | 51285-367 |
Product Type | Human Prescription Drug |
Proprietary Name | Trexall |
Generic Name | Methotrexate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2001-05-03 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA040385 |
Labeler Name | Teva Women's Health, Inc. |
Substance Name | METHOTREXATE SODIUM |
Active Ingredient Strength | 8 mg/1 |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2001-05-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA040385 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2001-05-03 |
Ingredient | Strength |
---|---|
METHOTREXATE SODIUM | 7.5 mg/1 |
SPL SET ID: | e942f8db-510f-44d6-acb5-b822196f5e8c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
51285-367 | Trexall | Trexall |
51285-368 | Trexall | Trexall |
51285-369 | Trexall | Trexall |
51285-366 | Trexall | Trexall |
0143-9367 | Methotrexate | Methotrexate |
0143-9516 | Methotrexate | Methotrexate |
0143-9517 | Methotrexate | Methotrexate |
0143-9518 | Methotrexate | Methotrexate |
0143-9519 | Methotrexate | Methotrexate |
0143-9830 | Methotrexate | Methotrexate |
0378-0014 | Methotrexate | methotrexate |
0555-0572 | Methotrexate | Methotrexate |
0703-3671 | Methotrexate | Methotrexate |
0703-3675 | Methotrexate | Methotrexate |
0703-3678 | Methotrexate | Methotrexate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TREXALL 76063551 3612756 Live/Registered |
Barr Laboratories, Inc. 2000-05-23 |